On a per-share basis, the Coral Gables, Florida-based company said it had a loss of 5 cents. The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment ...
Florida-based Catalyst Pharmaceuticals Inc.'s stock finished last Friday's session 4.73% lower at $2.62. A total volume …
Is it deal or no deal for CERU? We'll have to wait and see. 2. Catalyst Pharmaceuticals Inc. (CPRX) Gained 32.48% to close Wednesday's trading at $1.55.
(Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable …
I'm on the Space Coast of Florida so depending on what this storm does I may not be on for a while.It took almost 2 weeks to get power after Matthew last year so this could get ugly.For anyone in the path of this monster I wish you luck.Stay …
Florida-based Catalyst Pharmaceuticals Inc.'s stock finished last Friday's session 4.73% lower at $2.62. A total volume …
NEW YORK, NY / ACCESSWIRE / August 10, 2017 / Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) will be discussing their earnings results in their Q2 Earnings Call to be held on Thursday, August 10, 2017 at
*Close price adjusted for splits.**Adjusted close price adjusted for both dividends and splits. Loading more data...
Catalyst Pharmaceuticals Inc : Catalyst Pharmaceuticals announces second quarter 2016 financial results and provides product development update . Q2 earnings per share view $-0.08 -- Thomson Reuters I/B/E/S . Q2 GAAP loss per …